International Journal of Angiology

, Volume 5, Issue 1, pp 8–14 | Cite as

Effects of nilvadipine, a calcium antagonist, on intimal thickness of vascular grafting in cholesterol-fed rabbits

  • Koichi Yoshimura
  • Kensuke Esato
  • Kentaro Fujioka
Original Articles


The effects of nilvadipine on intimal thickness in expanded poly-tetrafluoroethylene grafts were examined in 21 rabbits undergoing infrarenal aorta reconstruction. Seven rabbits received commercial rabbit chow (control group), seven, a regular diet supplemented with 1% cholesterol (cholesterol group); and seven, the cholesterol diet with 98.9% pure nilvadipine 1 mg/kg/day (nilvadipine group). Grafts were harvested 3 months after surgery for histologic examination. Intimal thickness at the proximal and distal anastomosis was, respectively, 225±76 and 273±110 m in the control group, 525±236 and 600±250 m in the cholesterol group, and 284±94 and 241±86 m in the nilvadipine group. Intimal thickness in the cholesterol group was significantly greater than in the nilvadipine group (p<0.01). The smooth muscle cell values in the intima at the proximal and distal anastomosis were, respectively, 10.6±3.6 and 12.6±3.2 %Extinction (%E) in the control group, 15.5±4.0 and 16.1±4.5 %E in the cholesterol group, and 9.1±3.1 and 9.6±2.1 %E in the nilvadipine group. The smooth muscle cell value in the intima of the cholesterol group was greater than that of the nilvadipine group (p<0.01). These data suggest that nilvadipine significantly reduces the degree of intimal thickness in expanded polytetrafluoroethylene grafts in cholesterol-fed rabbits, and that this effect is due to inhibition of smooth muscle cell migration and proliferation.


Cholesterol Smooth Muscle Cell Calcium Antagonist Cholesterol Diet Vascular Grafting 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Conti CR, Pepine CJ, Feldman RL, Hill JA (1985) Calcium antagonists. Cardiology 72:297–321.PubMedGoogle Scholar
  2. 2.
    Henry PD, Bentley KI (1981) Suppression of atherogenesis in cholesterol-fed rabbits treated with nifedipine. J Clin Invest 68: 1366–1369.PubMedGoogle Scholar
  3. 3.
    Stender S, Ravn H, Haugegaard M, Kjeldsen K (1986) Effect of verapamil on accumulation of free and esterified cholesterol in the thoracic aorta of cholesterol-fed rabbits. Atherosclerosis 61: 15–23.PubMedGoogle Scholar
  4. 4.
    El-Sanadiki MN, Cross KS, Mikt EM, Hagen P-O (1987) Verapamil therapy reduces intimal hyperplasia in balloon-injured rabbit aorta. Circulation 76(suppl):314.Google Scholar
  5. 5.
    Sugano M, Nakashima Y, Matushima T (1986) Suppression of atherosclerosis in cholesterol-fed rabbits by dilitiazem injection. Atherosclerosis 6:237–241.Google Scholar
  6. 6.
    Ginsburg R, Davis K, Bristow MR, McKennett K, Kodsi SR, Billingham ME, Schroeder J (1983) Calcium antagonists suppress atherogenesis in aorta but not in intramural coronary arteries of cholesterol-fed rabbits. Lab Invest 49:154–158.PubMedGoogle Scholar
  7. 7.
    Nomoto A, Hirosumi J, Sekiguchi C, Mutoh S, Yamaguchi I, Aoki H (1987) Antiatherogenic activity of FR34235(nilvadipine), a new potent calcium antagonist. Atherosclerosis 64:255–261.PubMedGoogle Scholar
  8. 8.
    Mutoh S, Nomoto A, Sekiguchi C, Yamaguchi I (1988) Protective action of a calcium antagonist, nilvadipine, against aortic calcium deposition—a pathogenic factor in atherosclerosis. Atherosclerosis 73:181–189.CrossRefPubMedGoogle Scholar
  9. 9.
    Nomoto A, Mutoh S, Hagiwara H, Yamaguchi I (1988) Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a point calcium antagonist, nilvadipine. Atherosclerosis 72:213–219.CrossRefPubMedGoogle Scholar
  10. 10.
    Koibuchi Y, Sakai S, Miura S, Ono T, Shibayama F, Ohtsuka M (1989) Suppression of atherogenesis in cholesterol-fed rabbits treated with nilvadipine, a new vasoselective calcium entry blocker. Atherosclerosis 79:147–155.CrossRefPubMedGoogle Scholar
  11. 11.
    Umeda T, Naomi S, Iwaoka D, Inoue J, Ohno M, Hamazaki S, Miura F, Sato T (1986) The antihypertensive effect and pharmacokinetics of nilvadipine(FK235) in essential hypertension. Jpn J Clin Pharmacol Ther 17:735–748.Google Scholar
  12. 12.
    Ohtsuka M, Ono T, Shibayama F (1988) Nilvadipine. Cardiovasc Drug Rev 6:97–115.Google Scholar
  13. 13.
    O-hara M, Esato K, Mohri H (1988) Effect of pancreatopeptidase E (Elastase) on the suppression of intimal fibrous proliferation after arterial reconstruction in high cholesterol fed rabbits. J Cardiovasc Surg 29:268–276.Google Scholar
  14. 14.
    O-hara M, Esato K, Harada M, Kouchi Y, Akimoto F, Nakamura T, Wakamatsu T, Zempo N (1991) Eicosapentanoic acid suppresses intimal hyperplasia after expanded polytetrafluoroethlene grafting in rabbits fed a high cholesterol diet. J Vasc Surg 13:480–486.CrossRefPubMedGoogle Scholar
  15. 15.
    Clowes AW, Reidy MA (1991) Prevention of stenosis after vascular reconstruction: Pharmacologic control of intimal hyperplasia—a review. J Vasc Surg 13:885–891.PubMedGoogle Scholar
  16. 16.
    Ross R (1986) The pathogenesis of atherosclerosis—an update. N Engl J Med 20:488–500.Google Scholar
  17. 17.
    Ross R, Glomset J, Kariya B, Harker L (1974) A plateletdependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 71:1207–1210.PubMedGoogle Scholar
  18. 18.
    Clowes AW, Reidy MA, Clowes MM (1983) Kinetics of cellular proliferation after arterial injury: I. Smooth muscle growth in the absence of endothelium. Lab Invest 49:327–333.PubMedGoogle Scholar
  19. 19.
    Walker LN, Bowen-Pope DF, Ross R, Reidy MA (1986) Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci USA 83:7311–7315.PubMedGoogle Scholar
  20. 20.
    Nilsson J, Sjolund M, Palmberg L, Von Euler AM, Jonzon B, Thyberg J (1985) The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation. Atherosclerosis 58:109–122.PubMedGoogle Scholar
  21. 21.
    Nakao J, Ito H, Ooyama T, Chang WC, Murota S (1983) Calcium dependency of aortic smooth muscle cell migration induced by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. Atherosclerosis 46:309–319.CrossRefPubMedGoogle Scholar
  22. 22.
    Weinstein DB, Heider JG (1987) Antiatherogenic properties of calcium antagonist. Am J Cardiol 59:163B-172B.CrossRefPubMedGoogle Scholar
  23. 23.
    Mutoh S, Nomoto A, Hirosumi J, Sekiguchi C, Yamaguchi I, Aoki H (1987) Antiatherogenic activity of FR34235(Nilvadipine), a new potent calcium antagonist: Effect on cuff-induced intimal thickening of rabbit carotid artery (Japanese). Domyakukoka 15:115–120.Google Scholar
  24. 24.
    Blumlein SL, Sievers R, Kidd P, Parmley WW (1984) Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit. Am J Cardiol 54:884–889.PubMedGoogle Scholar
  25. 25.
    Henry PD, Bentley KI (1981) Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine. J Clin Invest 68: 1366–1369.PubMedGoogle Scholar
  26. 26.
    Handley DA, Van Valen RG, Melden MK, Saunders RN (1986) Suppression of rat carotid lesion development by the calcium channel blocker PN 200-110. Am J Pathol 124:88–93.PubMedGoogle Scholar
  27. 27.
    El-Sanadiki MN, Cross KS, Murray JJ, Schuman RW, Mikat E, McCann RL, Hagen P (1989) Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment. Ann Surg 212:87–96.Google Scholar
  28. 28.
    Groves HM, Kinlough-Rathbone RL, Mustard JF (1986) Development of non-thrombogenicity of injured rabbit aortas despite inhibition of platelet adherence. Atherosclerosis 6:189–195.Google Scholar
  29. 29.
    Srivastava KC (1986) Effects of dipyridamole, nifedipine, verapamil, hydraladine and propranolol on the formation of prostacyclin and thromboxane in a coupled system of platelets and aorta. Prostaglandins Leuko Med 23:31–36.CrossRefGoogle Scholar
  30. 30.
    Jackson CL, Bush RC, Bowyer DE (1988) Inhibition effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size. Atherosclerosis 69: 115–122.PubMedGoogle Scholar
  31. 31.
    Horiuchi I, Kawamoto T, Okamoto M, Ohshima T, Takizawa I, Kawakami M, Maruhashi A, Kanazawa I, Sasaki H, Kubota S, Okuhara T, Mitsuda H, Oyamada K, Fujiyama M, Yamada K, Yokote Y, Fujii H, Kido K, Kajiyama G (1986) Effect of nilvadipine treatment on lipoprotein metabolism and hypertension (Japanese). Geriat Med 24:1671–1679.Google Scholar
  32. 32.
    Hasegawa M, Saito M, Fukunaga Y, Abe N, Takeuchi K, Arai C, Takayama Y (1984) Studies on the histochemical quantitation of cell nuclei, smooth muscle cell, various connective tissues and calcium phosphate. I (Japanese). Rinsho-byori 32:801–808.PubMedGoogle Scholar

Copyright information

© International College of Angiology, Inc. 1996

Authors and Affiliations

  • Koichi Yoshimura
    • 1
  • Kensuke Esato
    • 1
  • Kentaro Fujioka
    • 1
  1. 1.First Department of SurgeryYamaguchi University School of MedicineYamaguchiJapan

Personalised recommendations